- Home
- NRXP vs WVVI Comparison
NRXP vs WVVI Comparison
Compare NRXP & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- WVVI
- Stock Information
- Founded
- NRXP 2015
- WVVI 1983
- Country
- NRXP United States
- WVVI United States
- Employees
- NRXP N/A
- WVVI N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- NRXP Health Care
- WVVI Consumer Staples
- Exchange
- NRXP Nasdaq
- WVVI Nasdaq
- Market Cap
- NRXP 48.5M
- WVVI 17.4M
- IPO Year
- NRXP N/A
- WVVI N/A
- Fundamental
- Price
- NRXP $4.01
- WVVI $4.70
- Analyst Decision
- NRXP Strong Buy
- WVVI
- Analyst Count
- NRXP 3
- WVVI 0
- Target Price
- NRXP $31.67
- WVVI N/A
- AVG Volume (30 Days)
- NRXP 2.8M
- WVVI 9.7K
- Earning Date
- NRXP 11-14-2024
- WVVI 11-12-2024
- Dividend Yield
- NRXP N/A
- WVVI N/A
- EPS Growth
- NRXP N/A
- WVVI N/A
- EPS
- NRXP N/A
- WVVI N/A
- Revenue
- NRXP N/A
- WVVI $39,259,016.00
- Revenue This Year
- NRXP N/A
- WVVI N/A
- Revenue Next Year
- NRXP N/A
- WVVI N/A
- P/E Ratio
- NRXP N/A
- WVVI N/A
- Revenue Growth
- NRXP N/A
- WVVI N/A
- 52 Week Low
- NRXP $1.10
- WVVI $3.17
- 52 Week High
- NRXP $7.33
- WVVI $5.34
- Technical
- Relative Strength Index (RSI)
- NRXP 61.48
- WVVI 82.84
- Support Level
- NRXP $3.20
- WVVI $3.40
- Resistance Level
- NRXP $6.01
- WVVI $5.01
- Average True Range (ATR)
- NRXP 0.95
- WVVI 0.28
- MACD
- NRXP 0.11
- WVVI 0.14
- Stochastic Oscillator
- NRXP 56.52
- WVVI 82.29
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.